Literature DB >> 9736660

A protein kinase, PKN, accumulates in Alzheimer neurofibrillary tangles and associated endoplasmic reticulum-derived vesicles and phosphorylates tau protein.

T Kawamata1, T Taniguchi, H Mukai, M Kitagawa, T Hashimoto, K Maeda, Y Ono, C Tanaka.   

Abstract

A possible role for a protein kinase, PKN, a fatty acid-activated serine/threonine kinase with a catalytic domain homologous to the protein kinase C family and a direct target for Rho, was investigated in the pathology of Alzheimer's disease (AD) using a sensitive immunocytochemistry on postmortem human brain tissues and a kinase assay for human tau protein. The present study provides evidences by light, electron, and confocal laser microscopy that in control human brains, PKN is enriched in neurons, where the kinase is concentrated in a subset of endoplasmic reticulum (ER) and ER-derived vesicles localized to the apical compartment of juxtanuclear cytoplasm, as well as late endosomes, multivesicular bodies, Golgi bodies, secretary vesicles, and nuclei. In AD-affected neurons, PKN was redistributed to the cortical cytoplasm and neurites and was closely associated with neurofibrillary tangles (NFTs) and their major constituent, abnormally modified tau. PKN was also found in degenerative neurites within senile plaques. In addition, we report that human tau protein is directly phosphorylated by PKN both in vitro and in vivo. Thus, our results suggest a specific role for PKN in NFT formation and neurodegeneration in AD damaged neurons.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9736660      PMCID: PMC6793236     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  43 in total

1.  Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease.

Authors:  W Xia; J Zhang; R Perez; E H Koo; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Characterization of the interaction between RhoA and the amino-terminal region of PKN.

Authors:  H Shibata; H Mukai; Y Inagaki; Y Homma; K Kimura; K Kaibuchi; S Narumiya; Y Ono
Journal:  FEBS Lett       Date:  1996-05-06       Impact factor: 4.124

3.  MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption.

Authors:  G Drewes; A Ebneth; U Preuss; E M Mandelkow; E Mandelkow
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

4.  Domain-specific phosphorylation of vimentin and glial fibrillary acidic protein by PKN.

Authors:  K Matsuzawa; H Kosako; N Inagaki; H Shibata; H Mukai; Y Ono; M Amano; K Kaibuchi; Y Matsuura; I Azuma; M Inagaki
Journal:  Biochem Biophys Res Commun       Date:  1997-05-29       Impact factor: 3.575

5.  Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II.

Authors:  H Yamaguchi; K Ishiguro; T Uchida; A Takashima; C A Lemere; K Imahori
Journal:  Acta Neuropathol       Date:  1996-09       Impact factor: 17.088

6.  Paired helical filaments and the cytoplasmic-nuclear interface in Alzheimer's disease.

Authors:  J Metuzals; Y Robitaille; S Houghton; S Gauthier; R Leblanc
Journal:  J Neurocytol       Date:  1988-12

7.  Purification and characterization of a fatty acid-activated protein kinase (PKN) from rat testis.

Authors:  M Kitagawa; H Mukai; H Shibata; Y Ono
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

8.  Activation of PKN, a novel 120-kDa protein kinase with leucine zipper-like sequences, by unsaturated fatty acids and by limited proteolysis.

Authors:  H Mukai; M Kitagawa; H Shibata; H Takanaga; K Mori; M Shimakawa; M Miyahara; K Hirao; Y Ono
Journal:  Biochem Biophys Res Commun       Date:  1994-10-14       Impact factor: 3.575

Review 9.  Phospholipase A2 and its role in brain tissue.

Authors:  A A Farooqui; H C Yang; T A Rosenberger; L A Horrocks
Journal:  J Neurochem       Date:  1997-09       Impact factor: 5.372

10.  Immune system response in Alzheimer's disease.

Authors:  P L McGeer; H Akiyama; S Itagaki; E G McGeer
Journal:  Can J Neurol Sci       Date:  1989-11       Impact factor: 2.104

View more
  21 in total

1.  Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice.

Authors:  X Bi; A P Yong; J Zhou; C E Ribak; G Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 2.  The study of Golgi apparatus in Alzheimer's disease.

Authors:  Zhiping Hu; Liuwang Zeng; Zhiling Huang; Jie Zhang; Ting Li
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

3.  Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway.

Authors:  M J Marinissen; M Chiariello; J S Gutkind
Journal:  Genes Dev       Date:  2001-03-01       Impact factor: 11.361

4.  Activation of PKN mediates survival of cardiac myocytes in the heart during ischemia/reperfusion.

Authors:  Hiromitsu Takagi; Chiao-Po Hsu; Katsuya Kajimoto; Dan Shao; Yanfei Yang; Yasuhiro Maejima; Peiyong Zhai; Ghassan Yehia; Chikaomi Yamada; Daniela Zablocki; Junichi Sadoshima
Journal:  Circ Res       Date:  2010-07-01       Impact factor: 17.367

5.  Modulation of tau phosphorylation and intracellular localization by cellular stress.

Authors:  S M Jenkins; M Zinnerman; C Garner; G V Johnson
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

6.  Gene expression variability and the analysis of large-scale RNA-seq studies with the MDSeq.

Authors:  Di Ran; Z John Daye
Journal:  Nucleic Acids Res       Date:  2017-07-27       Impact factor: 16.971

7.  The Drosophila Pkn protein kinase is a Rho/Rac effector target required for dorsal closure during embryogenesis.

Authors:  Y Lu; J Settleman
Journal:  Genes Dev       Date:  1999-05-01       Impact factor: 11.361

Review 8.  New insight into neurodegeneration: the role of proteomics.

Authors:  Ramavati Pal; Guido Alves; Jan Petter Larsen; Simon Geir Møller
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

9.  Development of an intracellularly acting inhibitory peptide selective for PKN.

Authors:  Kazuhiro Shiga; Kentaro Takayama; Shiroh Futaki; Jessica E Hutti; Lewis C Cantley; Katsuko Ueki; Yoshitaka Ono; Hideyuki Mukai
Journal:  Biochem J       Date:  2009-12-23       Impact factor: 3.857

10.  Global analysis of phosphorylation of tau by the checkpoint kinases Chk1 and Chk2 in vitro.

Authors:  Jhoana Mendoza; Michiko Sekiya; Taizo Taniguchi; Koichi M Iijima; Rong Wang; Kanae Ando
Journal:  J Proteome Res       Date:  2013-04-26       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.